Calidi Biotherapeutics, Inc. CLDI
0.75 USD +0.09 (+13.83%)
At closeNov 3, 2026, 5:08 PM EST
0.74 -0.01 -1.43%
After hours · Nov 3, 5:08 PM ET
0.6298 Day range 0.7599
0.62 52-week range 27.04
- YTD
- -96.00%
- 1 year
- -96.94%
Financial health
Altman Z-Score
-36.45 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 4
Valuation
P/E -0.2×
FY 2020 5y median -0.4× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 1.3×
FY 2020 5y median -1.7× FY 2025
P/FCF -0.2×
FY 2020 5y median -0.9× FY 2025
EV/EBITDA -0.1×
FY 2020 5y median -1.3× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -425.4%
FY 2020 5y median -108.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -529.6%
FY 2020 5y median 48.4% FY 2025
ROIC -314.4%
FY 2020 5y median -238.5% FY 2025
ROA -224.7%
FY 2020 5y median -291.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income 7.1%
FY 2020 FY 2025
EPS (diluted) 83.3%
FY 2020 FY 2025
Free Cash Flow -8.6%
FY 2020 FY 2025
Financial Health
Current Ratio 1.6×
FY 2020 5y median 0.4× FY 2025
Quick Ratio 1.6×
FY 2020 5y median 0.4× FY 2025
Debt / Equity 0.7×
FY 2020 5y median -0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2020 5y median -0.2× FY 2025
Interest Coverage -97.8×
FY 2020 5y median -23.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31